1. Home
  2. ONVO vs DSS Comparison

ONVO vs DSS Comparison

Compare ONVO & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONVO
  • DSS
  • Stock Information
  • Founded
  • ONVO 2007
  • DSS 1984
  • Country
  • ONVO United States
  • DSS United States
  • Employees
  • ONVO N/A
  • DSS N/A
  • Industry
  • ONVO Biotechnology: Biological Products (No Diagnostic Substances)
  • DSS Containers/Packaging
  • Sector
  • ONVO Health Care
  • DSS Consumer Discretionary
  • Exchange
  • ONVO Nasdaq
  • DSS Nasdaq
  • Market Cap
  • ONVO 5.6M
  • DSS 7.3M
  • IPO Year
  • ONVO N/A
  • DSS N/A
  • Fundamental
  • Price
  • ONVO $0.45
  • DSS $0.90
  • Analyst Decision
  • ONVO
  • DSS
  • Analyst Count
  • ONVO 0
  • DSS 0
  • Target Price
  • ONVO N/A
  • DSS N/A
  • AVG Volume (30 Days)
  • ONVO 214.6K
  • DSS 69.0K
  • Earning Date
  • ONVO 02-06-2025
  • DSS 11-13-2024
  • Dividend Yield
  • ONVO N/A
  • DSS N/A
  • EPS Growth
  • ONVO N/A
  • DSS N/A
  • EPS
  • ONVO N/A
  • DSS N/A
  • Revenue
  • ONVO $103,000.00
  • DSS $25,019,000.00
  • Revenue This Year
  • ONVO $59.08
  • DSS N/A
  • Revenue Next Year
  • ONVO $18.24
  • DSS N/A
  • P/E Ratio
  • ONVO N/A
  • DSS N/A
  • Revenue Growth
  • ONVO N/A
  • DSS N/A
  • 52 Week Low
  • ONVO $0.32
  • DSS $0.81
  • 52 Week High
  • ONVO $1.74
  • DSS $2.78
  • Technical
  • Relative Strength Index (RSI)
  • ONVO 59.27
  • DSS 44.84
  • Support Level
  • ONVO $0.42
  • DSS $0.89
  • Resistance Level
  • ONVO $0.52
  • DSS $1.04
  • Average True Range (ATR)
  • ONVO 0.05
  • DSS 0.09
  • MACD
  • ONVO 0.01
  • DSS 0.01
  • Stochastic Oscillator
  • ONVO 65.53
  • DSS 22.89

About ONVO Organovo Holdings Inc.

Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.

About DSS DSS Inc.

DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia.

Share on Social Networks: